G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: Results of a randomized BNLI trial

British Journal of Haematology

Volumn 99, Issue 4, 1997, Pages 933-938

  Linch, David C ^a,i   Milligan, Donald W ^b   Winfield, David A ^c   Kelsey, Stephen M ^d   Johnson, Stephen A ^e   Littlewood, Timothy J ^f   Smith, Graeme M ^g   Hutchinson, Robert M ^h   Goldstone, Anthony H ^a   Fielding, Adele K ^a   Hudson, Gillian Vaughan ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

^e TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^g LEEDS GENERAL INFIRMARY   (United Kingdom)

^h LEICESTER ROYAL INFIRMARY   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

BEAM; Haemopoietic recovery; Lenograstim; Lymphoma; PBSCT

Indexed keywords

CARMUSTINE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HEMATOPOIESIS; HODGKIN DISEASE; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PHASE 3 CLINICAL TRIAL; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 6844239543     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.4703274.x     Document Type: Article

References (21)

1. Bensinger, W., Appelbaum, F., Rowley, S., Storb, R., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffman, K., Weaver, C., Clift, R., Chauncey, T., Klarnet, J., Montgomery, P., Petersdorf, S., Weiden, P., Witherspoon, R. & Buckner, C. (1995) Factors that influence collection and engraftment of autologous peripheral blood stem cells. Journal of Clinical Oncology, 13, 2547-2555.
2. Chopra, R., McMillan, A.K. & Linch, D.C. (1993) The place of high-dose BEAM therapy and ABMT in poor-prognosis Hodgkin's disease: a single-centre eight-year study of 155 patients. Blood, 81, 1137-1145.
3. Demirer, T. & Bensinger, W.I. (1995) Optimization of peripheral blood stem cell collection. Current Opinion in Haematology, 2, 219-226.
4. Dunlop, D.J., Fitzsimons, E.J., McMurray, A., Morrison, M., Kyie, E., Alcorn, M.J. & Steward, W.P. (1994) Filgrastim falls to improve haernopoietic reconstitution following myeloablative chemotherapy and peripheral blood stem cell rescue. British Journal of Cancer, 70, 943-945.
5. Gianni, A.M., Bregini, M., Siena, S., Villa, S., Sciorelli, G.A., Ravagnani, F., Pellegris, G. & Bonnadonna, G. (1989) Rapid and complete hematological reconstitution following combined transplantation of autologous blood and bone marrow cells: a changing role for high dose chemo-radiotherapy? Hematological Oncology, 7, 139-148.
6. Gisselbrecht, C., Prentice, H.G., Bacigalupo, A., Biron, P., Milpied, N., Ruble, H., Cunningham, D., Legros, M., Pico, J.L., Linch, D.C., Burnett, A.K., Scarffe, J.H., Siegert, W. & Yver, A. (1994) Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation. Lancet, 343, 696-700.
7. Haioun, C., Lepage, E., Gisselbrecht, C., Coiffier, B., Bosly, A., Dupriez, B., Nouvel, C., Tilly, H., Lederlin, P., Biron, P., Briere, J., Gaulard, P. & Reyes, F. (1995) Autologous bone marrow transplantation (ABMT) versus sequential chemotherapy for aggressive non-Hodgkin's lymphoma (NHL) in first complete remission (CR): a study of 542 patients (LNH87-2 protocol). Blood, 86, 457a.
8. Höglund, M., Bengtsson, M., Cour-Chabernaud, V., Dabouz-Harrouche, F., Simmonsson, B., Smedmyr, B. & Tötterman, T. (1995) Glycosylated rHuG-CSF is more potent than non-glycosylated rHuG-CSF in mobilisation of peripheral blood progenitor cells (PBPC) in healthy volunteers. Blood, 86, 464a.
9. Jones, H.M., Jones, S.A., Watts, M.J., Khwaja, A., Mills, W., Fielding, A., Goldstone, A.H. & Linch, D.C. (1994) Development of a simplified single apheresis approach for peripheral blood progenitor cell transplantation in previously treated patients with lymphoma. Journal of Clinical Oncology, 12, 1693-1702.
10. Klumpp, T., Mangan, K.F., Goldberg, S.L., Pearlman, E.S. & Macdonald, J.S. (1995) Granulocyte-colony stimulating factor accelerates neutrophil engraftment following peripheral-blood stem cell transplantation: a prospective, randomized trial. Journal of Clinical Oncology, 13, 1323-1327.
11. Linch, D.C., Scarffe, H., Proctor, S., Chopra, R., Taylor, P.R.A., Morgenstern, G., Cunningham, D., Burnett, A.K., Cawley, J.C., Franklin, I.M., Bell, A.J., Lister, T.A., Marcus, R.E., Newland, A.C., Parker, A.C. & Yver, A. (1993a) Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation. Bone Marrow Transplantation, 11, 307-311.
12. Linch, D.C., Winfield, D., Goldstone, A.H., Moir, D., Hancock, B., McMillan, A., Chopra, R., Milligan, D. & Vaughan Hudson, G. (1993b) Dose intensification with autologous hone marrow transplantation is effective in relapsed and resistant Hodgkin's disease: results of a BNLI randomized trial. Lancet, 341, 1051-1054.
13. Lowdell, M.W. & Bainbridge, D.R. (1996) External quality assurance for CD34 cell enumeration: results of a preliminary national trial, Bone Marrow Transplantation, 17, 849-853.
14. + cell estimation in leucapheresis products. Bone Marrow Transplantation, 18, 791-796.
15. McQuaker, I.G., Hunter, A.E., Miflin, G., Long, S.G. & Russell, N.H. (1995) Allogeneic PBPCT: a dose ranging study using lenograstim for mobilisation. Blood, 86, 582a.
16. Peters, W.P., Rosner, G., Ross, M., Vredenburgh, J., Meisenberg, B., Gilbert, C. & Kurtzburg, J. (1993) Comparative effects of granulocyte-macrophage colony stimulating factor (GM-CSF) and granulocyte colony stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy, Blood, 81, 1709-1719.
17. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., van der Lelie, H., Bron, D., Sonnefeld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., Coiffier, B., Biron, P., Mandelli, F. & Chauvin, F. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma, New England Journal of Medicine, 333, 1540-1545.
18. Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.H., Boogaerts, M.A., Ferrant, A., Demuynck, H.M.S., Link, H., Zander, A., Barge, A. & Borkett, K. (1996) Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet, 347, 353-357.
19. Spitzer. G., Adkins, D.R., Spencer, V., Dunphy, F.R., Petruska, P.J., Velasquez, W.S., Bowers, C.E., Kronmueller, N., Niemeyer, R. & McIntyre, W. (1994) Randomized study of growth factors post peripheral-blood stem cell transplant: neutrophil recovery is improved with modest clinical benefit. Journal of Clinical Oncology, 12, 661-670.
20. Tura, S., Zinzani, P.L., Mazza, P., Bocchia, M., Gherlinzoni, F., Pileri, S., Amadori, S., Martelli, M., Guglielmi, C., Papa, G., Antimi, M., Burgio, V.L., Martelli, M.F., Liberati, A.M., Falini, B., Calabresi, F., Ruggeri, E.M., Dammacco, F., Lauta, V.M., Lucarelli, G., Moretti, L. & Mandelli, F. (1992) ABMT vs DHAP in residual disease following third generation regimens for aggressive NHL. Blood, 80, 619a.
21. Watts, M.J., Sullivan, A.M., Jamieson, E., Pearce, R., Fielding, A., Goldstone, A.H. & Linch, D.C. (1997) Progenitor cell mobilization after low dose cyclophosphamide and G-CSF: an analysis of quality and quantity and predictive factors in 101 pretreated patients with malignant lymphoma. Journal of Clinical Oncology, 15, 535-546.